Surg Endosc25 Apr 2024
Laparoscopic liver resection was associated with less blood loss compared to enucleation in patients with high portal phase enhancement ratio. For patients with a portal phase enhancement ratio higher than 38.9%, the liver resection approach is recommended for giant hepatic hemangioma, while both approaches showed…
World J Gastroenterol24 Apr 2024
Radiofrequency ablation combined with sorafenib significantly improves liver function and survival rates in liver cancer patients with portal hypertension. Among 100 patients, the combined therapy group showed a higher total effective rate (82.00%) compared to the control group (56.00%). Prognostic factors include Child-Pugh grade, tumor…
HPB & Spleen24 Apr 2024
A nomogram was developed to predict overall survival and cancer-specific survival in patients with gastric cancer and liver metastasis, showing satisfactory performance. Factors influencing survival included age, chemotherapy, grade, metastasis sites, and treatment received. The nomogram can assist clinicians in planning follow-up and rehabilitation strategies…
Clin Gastroenterol Hepatol23 Apr 2024
Study evaluates optimal treatment strategies for nonfunctioning small pancreatic neuroendocrine neoplasms, highlighting the impact of tumor size and grade on lymph node metastasis, recurrence, and survival. Personalized treatment approaches considering tumor grading are recommended for heterogeneous nf-spnens. Tumor size >20 mm for net-g1 and >10…
Dig Liver Dis23 Apr 2024
Short MRI protocols demonstrate suitability for surveillance of intraductal papillary mucinous neoplasms (IPMNs). In a retrospective study, protocols with T1-weighted, T2-weighted, MRCP, and DWI sequences show high concordance with clinical decisions for IPMN management. Inter-observer agreement is substantial across different protocols. Short MRI protocols offer…
Br J Surg22 Apr 2024
Feasible and safe, hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy (HAIP-SYS) for colorectal liver metastases (CRLMs) showed promising results in a phase II study in the Netherlands. With a completion rate of 90% for two cycles, it demonstrated favorable disease control rates at…
Surg Endosc22 Apr 2024
Laparoscopic liver resection (LLR) matches open liver resection (OLR) in outcomes for ≥ 3 colorectal liver metastases (CRLM), showing similar morbidity, mortality, and survival rates. LLR offers shorter hospital stays, advocating its consideration for selected patients with high tumour burden disease. This study, analyzing 277 patients, demonstrates…
HPB & Spleen22 Apr 2024
New Zealand is a low-volume center for upper gastrointestinal surgery, with most complex procedures concentrated in national cancer centers. There is evidence of regionalization, where larger centers perform procedures more frequently. Palliative procedures are more widely performed, but indigenous Māori are less likely to be…
Ann Surg21 Apr 2024
Optimal lymphadenectomy of ≥20 lymph nodes in IPMN-derived PDAC is associated with improved overall survival. A minimum of 10 lymph nodes is needed for accurate nodal staging. Specific optimal cut-offs were identified for different types of surgeries.
Eur J Surg Oncol21 Apr 2024
BRAF mutations in colorectal cancer patients with liver metastases are linked to poorer survival outcomes. However, liver resection shows a significant 56% reduction in the risk of death for patients with BRAF-mutated colorectal liver metastases. Surgical intervention offers a clear survival benefit, with a reduced…